Fully automated fluorescent in situ hybridization (FISH) staining and digital analysis of HER2 in breast cancer: a validation study - Wikidata - awgldk - TriplyDB

Fully automated fluorescent in situ hybridization (FISH) staining and digital analysis of HER2 in breast cancer: a validation study

Fully automated fluorescent in situ hybridization (FISH) staining and digital analysis of HER2 in breast cancer: a validation study

http://www.wikidata.org/entity/Q35284728

about

Validation of break-apart and fusion MYC probes using a digital fluorescence in situ hybridization capture and imaging system.

P2860

Q38380157-2AFCFB40-7A95-408D-8CD7-140E60C7394A

P2860

Fully automated fluorescent in situ hybridization (FISH) staining and digital analysis of HER2 in breast cancer: a validation study

http://www.wikidata.org/entity/Q35284728

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Fully automated fluorescent in ...... ast cancer: a validation study

@ast

Fully automated fluorescent in ...... ast cancer: a validation study

@en

type

label

Fully automated fluorescent in ...... ast cancer: a validation study

@ast

Fully automated fluorescent in ...... ast cancer: a validation study

@en

prefLabel

Fully automated fluorescent in ...... ast cancer: a validation study

@ast

Fully automated fluorescent in ...... ast cancer: a validation study

@en

P1433

Q35284728-46238D4A-D926-4A6F-9479-61F1DABFBBCE

P1476

Q35284728-1305EA29-DE19-47BF-969B-C831DAB85DD1

P2093

Q35284728-05E417B2-83C5-49B3-A1A6-89C9042E01AF

Q35284728-221E89EC-D99E-4718-A126-8E9442CE2395

Q35284728-2E3B9CA7-FD0A-4A51-BC98-E5069FD5805C

Q35284728-2EB181E4-F4DD-46E2-88AD-B8EFBD943000

Q35284728-87734C47-C565-4F1D-A9D0-93766D93E01A

Q35284728-DAD817F3-7B91-49D4-A9D6-0CFB339E47CC

Q35284728-F7A06D6E-09F9-459C-BD24-674A42CC1D86

P2860

Q35284728-0D5ED027-E3F4-47DE-9765-79E8A323ADC4

Q35284728-132F9F23-5FC7-4575-AA20-B741F9EBB71A

Q35284728-16FF571E-006C-4646-B40F-364E903DF91F

Q35284728-196EADE5-9C35-46DB-99E8-292113CD5315

Q35284728-1B32BB80-50EA-4AED-88DD-69369A8290B7

Q35284728-25A349DB-B52A-4968-8444-CCADF2712FC1

Q35284728-310DE268-A59E-460A-A247-D9F256FEF0F6

Q35284728-4146F880-EA4E-4F09-85EE-FF62F418ABE6

Q35284728-4D44379A-1C43-4081-9B32-54680AD1025E

Q35284728-4FF01815-CDD7-4262-80B5-0D71ABA8A685

P304

Q35284728-0D346CF8-047F-413F-90FC-1838AF4AF2DB

P31

Q35284728-A489995D-3AEE-4628-AC05-3D9E70657CB4

P356

Q35284728-90B97C65-EF93-46EC-BFFC-AB7BA6069A42

P407

Q35284728-F22E5AE1-13D3-4EC9-8FE9-18BEC44DAA43

P433

Q35284728-C812379D-7DED-425A-925D-2AFB6FA265F8

P478

Q35284728-A464E017-29FA-40B7-81C7-02CD39A165BE

P577

Q35284728-0D847AB7-FB5A-44E2-928D-2F4F4D36F7CF

P5875

Q35284728-E6591C95-45D1-4C14-B016-91D26509B043

P698

Q35284728-3E68E95F-FCEF-4C13-B6C9-5C0F6DF47576

P932

Q35284728-FA6F016B-A9FC-4EE5-877C-B5189BBAC949

P356

JOURNAL.PONE.0123201

P1433

P1476

Fully automated fluorescent in ...... ast cancer: a validation study

@en

P2093

Deborah A J Kuperus

http://www.w3.org/2001/XMLSchema#string

Ed Schuuring

http://www.w3.org/2001/XMLSchema#string

Elise M J van der Logt

http://www.w3.org/2001/XMLSchema#string

James E Boers

http://www.w3.org/2001/XMLSchema#string

Jan W van Setten

http://www.w3.org/2001/XMLSchema#string

Marius C van den Heuvel

http://www.w3.org/2001/XMLSchema#string

Robby E Kibbelaar

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybrid

Utilization of HER2 genetic testing in a multi-institutional observational study.

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.

Comparison of automated and manual FISH for evaluation of HER2 gene status on breast carcinoma core biopsies.

Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach

Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens.

P304

e0123201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0123201

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281804670

http://www.w3.org/2001/XMLSchema#string

P698

25844540

http://www.w3.org/2001/XMLSchema#string

P932

4386817

http://www.w3.org/2001/XMLSchema#string